Palmer Glyn D, Attur Mukundan G, Yang Qing, Liu James, Moon Paxton, Beier Frank, Abramson Steven B
Division of Rheumatology, New York University School of Medicine and NYU Hospital for Joint Diseases, New York, New York, United States of America.
Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, The University of Western Ontario, London, Ontario, Canada.
PLoS One. 2014 May 29;9(5):e98388. doi: 10.1371/journal.pone.0098388. eCollection 2014.
F-spondin is a pericellular matrix protein upregulated in developing growth plate cartilage and articular cartilage during osteoarthritis. To address its function in bone and cartilage in vivo, we generated mice that were deficient for the F-spondin gene, Spon1. Spon1-/- mice were viable and developed normally to adulthood with no major skeletal abnormalities. At 6 months, femurs and tibiae of Spon1-/- mice exhibited increased bone mass, evidenced by histological staining and micro CT analyses, which persisted up to 12 months. In contrast, no major abnormalities were observed in articular cartilage at any age group. Immunohistochemical staining of femurs and tibiae revealed increased levels of periostin, alkaline phosphate and tartrate resistant acid phosphatase (TRAP) activity in the growth plate region of Spon1-/- mice, suggesting elevated bone synthesis and turnover. However, there were no differences in serum levels of TRAP, the bone resorption marker, CTX-1, or osteoclast differentiation potential between genotypes. Knockout mice also exhibited reduced levels of TGF-β1 in serum and cultured costal chondrocytes relative to wild type. This was accompanied by increased levels of the BMP-regulatory SMADs, P-SMAD1/5 in tibiae and chondrocytes. Our findings indicate a previously unrecognized role for Spon1 as a negative regulator of bone mass. We speculate that Spon1 deletion leads to a local and systemic reduction of TGF-β levels resulting in increased BMP signaling and increased bone deposition in adult mice.
F-spondin是一种细胞周围基质蛋白,在骨关节炎期间发育中的生长板软骨和关节软骨中上调。为了研究其在体内骨骼和软骨中的功能,我们构建了F-spondin基因Spon1缺失的小鼠。Spon1基因敲除小鼠存活且正常发育至成年,无明显骨骼异常。6个月时,Spon1基因敲除小鼠的股骨和胫骨骨量增加,组织学染色和显微CT分析证实了这一点,并持续至12个月。相比之下,在任何年龄组的关节软骨中均未观察到明显异常。对股骨和胫骨的免疫组织化学染色显示,Spon1基因敲除小鼠生长板区域的骨膜蛋白、碱性磷酸酶和抗酒石酸酸性磷酸酶(TRAP)活性水平升高,提示骨合成和骨转换增加。然而,不同基因型之间骨吸收标志物TRAP、CTX-1的血清水平或破骨细胞分化潜能并无差异。与野生型相比,基因敲除小鼠血清和培养的肋软骨细胞中TGF-β1水平也降低。同时,胫骨和软骨细胞中骨形态发生蛋白(BMP)调节的SMADs、磷酸化SMAD1/5水平升高。我们的研究结果表明,Spon1作为骨量的负调节因子具有此前未被认识到的作用。我们推测,Spon1基因缺失导致TGF-β水平局部和全身降低,从而导致成年小鼠BMP信号增加和骨沉积增加。